B.C. limits sales of two more diabetes drugs amid off-label use for weight loss
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$0 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*No charge for 4 weeks then price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
*Your next subscription payment will increase by $1.00 and you will be charged $16.99 plus GST for four weeks. After four weeks, your payment will increase to $23.99 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
VICTORIA – British Columbia’s Health Ministry is limiting the sales of two more diabetes drugs to curb their off-label use for weight loss and preserve supply for people who are diabetic.
The limits on sales of Type 2 diabetes drugs tirzepatide and dulaglutide come after a 2023 regulation limited sales of semaglutide, which is sold under the band name Ozempic.
The rules mean B.C. pharmacists will not be able to sell the drugs to people who are not citizens or permanent residents of Canada and are not at the pharmacy in person.
Health Minister Josie Osborne says the drugs’ use for weight loss is driving shortages in several countries, including the United States.
She says the province is working to ensure people living with diabetes have access to the medications they need, although non-residents and foreign citizens with a valid Canadian prescription can still buy them in person.
Tirzepatide and dulaglutide are commonly sold under the brand names Mounjaro and Trulicity.
The ministry says the College of Pharmacists of B.C. is responsible for ensuring that college registrants comply with the regulation.
This report by The Canadian Press was first published July 17, 2025.